research.
Short-term Use of Brainberry Improves Cognitive Performance
Solabia Nutrition has published novel clinical data on the effect of Brainberry in supporting cognitive function, showing a significant improvement in psychomotor speed and BDNF levels after 1 week of supplementation. Brainberry was the first Aronia melanocarpa extract clinically tested in an earlier double-blind placebo-controlled trial. In the first trial, Brainberry intake resulted in significant improvement in focus and psycho-motor control and an increase in cognitive flexibility.
NXT USA’s Digexin Blend Improves Digestive Health and Mood
The results of a recent double-blind, randomized clinical study show that Digexin alleviates functional constipation, reduces gastrointestinal (GI) transit time, and improves bowel function, quality of life, and mental health.
Grains of Paradise Enhance Mental Wellbeing and Sleep Quality
Nektium’s new Vanizem botanical extract can significantly improve mood, reduce stress levels, and enhance sleep quality within just three days, a pilot study has found. Created from the West African spice Aframomum melegueta, the ingredient can be used to create mood-boosting supplements and other products without any sedative effects.
Cucumber Extract Improves Joint Health and Muscle Function
The new cucumber extract (Cucumis sativus L.) CuberUp, by botanical extracts and natural active substances producer Euromed, has been shown to relieve joint pain and improve muscle function in a double-blind clinical study. The study will be presented at the 14th Congress of Phytotherapy of the Spanish Society of Phytotherapy.
Phynova Study Reveals ‘Real Meal’ Blood Sugar Benefits with Low Dose Reducose
Researchers from Oxford Brookes Centre for Nutrition and Health, UK, and ingredient supplier Phynova Group Limited conducted the double-blind, randomized, placebo-controlled, repeat-measure, crossover design trial to test the efficacy of Reducose. A total of 37 healthy individuals (men and women aged 18-56) completed the study. Participants consumed capsules containing either 200 mg, 225 mg, 250 mg Reducose, or placebo before a test meal consisting of 150 g white bread and egg mayo filler. Capillary blood samples were collected at 15-minute intervals in the first hour and at 30-minute intervals over the second and third hours to determine glucose and plasma insulin levels. The consumption of all three doses of Reducose resulted in significantly lower blood glucose and plasma insulin levels compared to placebo. All three doses (200 mg, 225 mg, 250 mg) of Reducose significantly lowered glucose iAUC 120 by 30%, 33% and 32%, respectively, compared with placebo. All three doses significantly lowered the plasma insulin iAUC 120 by 31% (p = 0.024), 34% (p = 0.004), and 38% (p < 0.001), respectively.
Cellf 2.0 Boosts Availability of Cellular Health Support
Mikra Cellular Sciences, a subsidiary of Canada-based Lifeist Wellness, has partnered with Virun NutraBiosciences to evolve its nutraceutical gel for cellular health support. The new Cellf 2.0 version launched this month, packaging its CoQ10, Pyrroloquinoline Quinone (PQQ), and glutathione ingredients in a liposomal delivery system with an enhanced taste and price point. A double-blind, placebo-controlled study showed that 20 mg per day for 12 weeks improved composite and verbal memory.
SunActive Studies Impact of Emulsified Microsomal Iron in Pregnancy
In a new Indian study, researchers investigated the safety and effectiveness of 30 mg SunActive Fe emulsified microsomal ferric pyrophosphate (EMFP) tablets for treating iron deficiency anemia (IDA) in second-trimester pregnant women. After the intervention, the researchers found that subjects’ serum ferritin levels [which are directly related to the amount of iron in the body] increased 6.61-fold. Serum iron also increased by 46.9%. Adverse symptoms like irritability and heartburn were reduced while subjects reported less overall fatigue.
Zoe Hails Personalized Nutrition Trial Success, Results Come Under Scrutiny
Zoe has announced the results of its long-awaited trial comparing its personalized dietary program (PDP) to standard healthcare advice, but the publication has drawn criticism over methodology and results. The researchers from the UK-based personalized nutrition firm compared the impact of the program to general advice provided on cardiometabolic health in 347 participants over 18 weeks. Primary outcome results published in the journal Nature Medicine showed a significant reduction in triglycerides (TGs) in comparison to the control group, however, differences in low-density lipoprotein cholesterol were insignificant. For the researchers, the results were positive thanks to secondary outcomes such as improvements in body weight, waist circumference, microbiome diversity, and quality of life scores, leading them to conclude that a personalized nutrition program that addresses metabolic heterogeneity is effective in improving cardiometabolic health in generally healthy individuals. Published in Nature.
